US 10117899
Delivery methods and compositions for nuclease-mediated genome engineering in hematopoietic stem cells
granted A61KA61K2035/124A61K35/28
Quick answer
US patent 10117899 (Delivery methods and compositions for nuclease-mediated genome engineering in hematopoietic stem cells) held by Sangamo Therapeutics, Inc. expires Mon Nov 01 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Sangamo Therapeutics, Inc.
- Grant date
- Tue Nov 06 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 01 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 11
- CPC classes
- A61K, A61K2035/124, A61K35/28, A61K48/00, A61K48/005